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ATP-binding cassette (ABC) proteins were first recognized for their role in multidrug
resistance (MDR) in chemotherapeutic treatments, which is a major impediment for
the successful treatment of many forms of malignant tumors in humans. These
proteins, highly conserved throughout vertebrate species, were later related to cellular
detoxification and accounted as responsible for protecting aquatic organisms from
xenobiotic insults in the so-called multixenobiotic resistance mechanism (MXR). In
recent years, research on these proteins in aquatic species has highlighted their
importance in the detoxification mechanisms in fish thus it is necessary to continue these
studies. Several transporters have been pointed out as relevant in the ecotoxicological
context associated to the transport of xenobiotics, such as P-glycoproteins (Pgps),
multidrug-resistance-associated proteins (MRPs 1-5) and breast cancer resistance
associated protein (BCRP). In mammals, several nuclear receptors have been identified
as mediators of phase I and II metabolizing enzymes and ABC transporters. In
aquatic species, knowledge on co-regulation of the detoxification mechanism is scarce
and needs to be addressed. The interaction of emergent contaminants that can act
as chemosensitizers, with ABC transporters in aquatic organisms can compromise
detoxification processes and have population effects and should be studied in more detail.
This review intends to summarize the recent advances in research on MXR mechanisms
in fish species, focusing in (1) regulation and functioning of ABC proteins; (2) cooperation
with phase I and II biotransformation enzymes; and (3) ecotoxicological relevance and
information on emergent pollutants with ability to modulate ABC transporters expression
and activity. Several lines of evidence are clearly suggesting the important role of these
transporters in detoxification mechanisms and must be further investigated in fish to
underlay the mechanism to consider their use as biomarkers in environmental monitoring.
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INTRODUCTION
The maintenance of the overall environmental health is quite
dependent on aquatic ecosystems. Species overexploitation, pol-
lution from urban, industrial and agricultural areas, as well as
habitat loss and alteration have been contributing to the decline
of aquatic environmental health. Toxic heavy metals resultant
from industrial processes, persistent organic pollutants (POPs)
from agricultural and industrial sources and polycyclic aromatic
hydrocarbons (PAHs) resultant from oil spills are among the
sources of major concern regarding water pollution, due to their
known toxic effects on the aquatic biota (Van Der Oost et al.,
2003; Weber et al., 2008). More recently, a highly diverse group
of contaminants, denominated emergent contaminants (EC),
substances that are detected in the environment but are not
included in regulatory monitoring programs are added as poten-
tial threats to ecosystems and human health and safety (Santos
et al., 2010; Celander, 2011). They encompass a large number of
compounds that include pharmaceuticals, hazardous and noxious
substances (HNS), personal care products (PPCPs), nanomate-
rials, among others (Farré et al., 2008). Some of these EC have
been receiving attention, since these compounds are continually
introduced into the aquatic environment as complex mixtures
via a number of routes, but primarily by both untreated and
treated sewage (Daughton and Ternes, 1999). In order to sur-
vive, living organisms have developed strategies of protection
to the adverse effects of pollutants. Chronically exposed organ-
isms use a well-developed detoxification mechanism in order to
reduce the toxic effects of pollutants (Van Der Oost et al., 2003).
These mechanisms include the activity of specific proteins to pre-
clude the permanence of toxic compounds or their metabolites
in the cells - some members of the ATP-Binding Cassette (ABC)
superfamily—and enzymatic systems to transform the chemicals
into a more easily excreted form—phase I and phase II biotrans-
formation enzymes. Thus, the knowledge of the functionality of
these detoxification pathways is of critical importance, to support
the availability of the aquatic resources for future generations.
The main points of this review will be the detoxification mech-
anisms adopted by fish species, focusing in (1) the regulation and
functioning of ABC transporters; (2) the cooperation with phase
I and II biotransformation enzymes; and (3) the ecotoxicological
relevance of emergent pollutants with ability to modulate ABC
transporters expression and activity. Recent studies have raised
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the possibility of a coordinated action between these groups of
proteins, resulting in a powerful and effective mechanism of
cellular detoxification.
THE SUPERFAMILY OF ABC EFFLUX TRANSPORTERS
The ABC genes represent one of the largest family of transmem-
brane transporter proteins encoded in the human genome (Dean
et al., 2001). These proteins bind to ATP and use that energy to
drive the transport of a wide variety of molecules across cellular
membranes (Table 1) (Dean and Annilo, 2005). So far, 58 mem-
bers of the ABC family have been described, including 49 human
ABC genes and 9 additional genes found in other animal species.
From the 58 genes, 68% are present in all vertebrate genomes,
suggesting that their structure and functions have been largely
conserved throughout the evolution of vertebrate species (Dean
and Annilo, 2005). Based on the sequence and the organization
of the ATP-binding domains, also known as nucleotide binding
domains (NBDs), ABC proteins were grouped into eight subfami-
lies in eukaryotes (A–H), with seven of these (A–G) present in the
human genome (Dean and Annilo, 2005), as shown in Table 1.
The ABCH subfamily has been identified so far only in zebrafish
and the function is still unknown (Popovic et al., 2010).
Typically, a functional protein contains two NBDs and two
membrane spanning domains (MSDs), the latter being composed
by 6–10 membrane spanning α-helices that confer the substrate
specificity (Figure 1) (Szakács et al., 2008). Eukaryotic ABC pro-
teins are organized either as full transporters (containing two
NBDs and two MSDs), or as half transporters (containing one
NBD and one MSD), that have to form homo- or heterodimers
in order to constitute a functional protein (Dean et al., 2001).
Some variation exists in protein structure in the different sub-
families, as it will be described further ahead, but a high degree
of structural and sequence homology is shared among all ABC
transporter proteins (Linton and Higgins, 2007).
MULTIDRUG RESISTANCE (MDR) ASSOCIATED ABC TRANSPORTERS
Juliano and Ling (1976) described a multidrug resistance (MDR)
phenomenon, found in tumor cell lines of mammals, as the
result of low intracellular accumulation of anti-cancer drugs, and
related it with the overexpression of a transmembrane protein,
responsible for an ATP-dependent efflux of those drugs into the
extracellular medium. This protein, denominated as Permeability
glycoprotein (Pgp) and encoded by the ABCB1 gene, was the first
ABC transporter to gain importance and later to be related to cel-
lular detoxification. From this point, several other members of
the ABC transporter efflux family, other than ABCB, have been
identified as capable of interacting with endo- or xenobiotic com-
pounds, including members of the ABCC and ABCG subfamilies
(Cole and Deeley, 1998; Costa et al., 2012b; Fischer et al., 2013;
Ferreira et al., 2014). Due to their ecotoxicological role these three
subfamilies of transporters will be addressed in more detail in the
following sections.
P-glycoprotein (Pgp)
The best characterized ABC transporter is Pgp (subfamily B,
member 1: ABCB1; MDR1). In humans, Pgp is encoded by two
different isoforms of the gene (MDR1 andMDR3); the class 1 has
been implicated in drug resistance whereas the function of class 3
isoform is still unknown (Georges et al., 1990). ABCB1 (MDR1)
was the first eukaryotic ABC member identified as results of its
implication in MDR of cancer cells to chemotherapy (Gottesman
and Ling, 2006). Further evidence of its MDR abilities included
decreased drug accumulation in cells transfected with ABCB1
gene (Ueda et al., 1987), and increased drug accumulation in
gene knockouts organisms, compared to the wild-type organism
(Schinkel et al., 1994). In humans, ABCB1 is a 170–180 kDa pro-
tein containing∼1280 amino acids, with a predicted four-domain
structure, typical of most eukaryotic ABC transporters, with two
NBDs each preceded by a MSD composed of six transmembrane
(TM) helices (Loo and Clarke, 1999) (Figure 2A). MDR provided
by Pgp is a consequence of its remarkable non-specificity with
respect to the substrates. Several researchers have focused their
attention on the understanding of the promiscuity of this trans-
porter regarding its substrates, and have indicated common char-
acteristics among them, such as moderate hydrophobicity, small
size and positively charged or neutral domains, and include nat-
ural products, chemotherapeutic drugs or steroids (Litman et al.,
2001; Higgins, 2007;McDevitt and Callaghan, 2007). Pgp can also
interact withmodulators that are able to reverseMDR by blocking
or saturating Pgp binding locations, called chemosensitizers.
The sister of P-glycoprotein (Spgp, ABCB11, BSEP), follows
the same predicted structure as ABCB1 (Figure 2A), and studies
Table 1 | List of known ABC genes, functions and number of members found in human and zebrafish genomes.
Subfamily Members Functions Human Zebrafish*
ABCA ABCA1 to ABCA13 Cholesterol efflux, phosphatidil choline efflux, N-retinylidiene-PE efflux 12 members 7 members
ABCB ABCB1 to ABCB11 Peptide transport, iron transport, Fe/S cluster transport, bile salt transport,
xenobiotics transport
11 members 9 members
ABCC ABCC1 to ABCC13 Organic anion efflux, nucleoside transport, chloride ion channel, sulfonylurea
receptor, potassium channel regulation, xenobiotics transport
13 members 11 members
ABCD ABCD1 to ABCD4 Very long chain fatty acids transport regulation 4 members 4 members
ABCE ABCE1 Elongation factor complex 1 member 1 member
ABCF ABCF1 to ABCF3 Unknown function 3 members 3 members
ABCG ABCG1 to ABCG5 Cholesterol transport, sterol transport, toxin transport 5 members 5 members
ABCH ABCH1 Unknown function No members 1 member
*These genomes are incompletely assembled and annotated and the gene numbers may be higher. Adapted from Dean and Annilo (2005).
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FIGURE 1 | Schematic representation of a typical ABC protein and
characteristic amino acid sequences found in Nucleotide Binding
Domains (NBDs). (A) Lipidic bilayer is shown in gray, membrane spanning
domains (MSDs) in light brown and nucleotide binding domains (NBDs) in
blue, dashed line represents the linker region; (B) aminoacid sequences
characteristic from the conserved domains Walker A (x represents any aa),
C-motif and Walker-B ( represents hydrophobic residues). Adapted from
Dean et al. (2001), with permission.
in rats showed predominant expression in liver, canalicular local-
ization, and high affinity to transport primary and secondary bile
salts (Gerloff et al., 1998). The role of ABCB11 in drug dispo-
sition, if any, is considerably more limited than that of its close
relative, Pgp.
MRPs—multiresistance associated proteins
After the discovery of ABCB1, the study on cancer cells display-
ing MDR phenotype not associated with ABCB1 expression, led
to the discovery of ABCC1, the founding member of the ABCC
subfamily (Cole et al., 1992). So far, this subfamily includes a
total of 13 members, most of which are active ATP-dependent
membrane transporters for organic anions of therapeutic com-
pounds (Honorat et al., 2009). Among its members, at least
five (ABCC1, ABCC2, ABCC3, ABCC4 and ABC5) are poten-
tially involved in mediating drug resistance (Cole et al., 1992;
Kool et al., 1997; Evers et al., 1998). Members of the ABCC sub-
family can fall in one of two different subclasses, “short” and
“long” (Kast and Gros, 1997; Bakos and Homolya, 2007; Honorat
et al., 2009). The so called “long” ABCC transporters (ABCC1,
2, 3, and 6) present an additional N- terminal MSD (MSD0), of
approximately 250 amino acids, a unique feature of these specific
transporters (Figure 2B) in comparison to the “short” trans-
porters. ABCCs are ∼190 kDa proteins, and share 14–25% amino
acid identity with ABCB proteins (Cole et al., 1992; Keppler and
Konig, 1997). From the ABCC subfamily, ABCC1 and ABCC2 are
the best characterized transporters with existing evidences from
animal models to have a role in organ defense, while other mem-
bers like ABCC3, 4, and 5, are far less studied (Mayer et al., 1995;
Keppler and Konig, 2000).
BCRP—breast cancer resistance protein
The second member of the ABCG subfamily, ABCG2, is
a∼72 kDa efflux transporter, whose overexpression in permanent
cell-lines has been associated with high levels of resistance to a
variety of anticancer drugs, such as mitoxantrone, doxorubicin,
and daunorubicin, without evidences of expression of the well-
characterized genes for ABCB1 or ABCCs therefore contributing
to a MDR phenotype. This protein is also known as breast resis-
tance associated protein (BCRP) (Doyle et al., 1998; Doyle and
Ross, 2003), mitoxantrone-resistance protein (MXR) (Miyake
et al., 1999) or placenta-specific ABC protein (ABCP) (Allikmets
et al., 1998) since it was cloned independently by 3 different
groups. Members of the ABCG subfamily have a unique domain
organization, since, unlike the remaining subfamilies, these are
half-transporters, composed by one single NBD followed by one
MSD (Figure 2C). In addition, they also present a unique pro-
tein configuration, in which the NBD precedes the MSD, whereas
ABCBs and ABCCs have an opposite domain arrangement, that
is, the MSD is followed by the NBD (Figure 2C).
Functional characterization studies have demonstrated that
ABCG2 can transport a wide range of substrates, from
chemotherapeutic agents to organic anion conjugates (Mao,
2005).Moreover, it seems that ABCG2 has higher affinity to trans-
port sulfated conjugates of steroids and xenobiotics over GSH and
glucoronide metabolites (Chen et al., 2003).
FROMMDR TO MXR—ABC EFFLUX TRANSPORTERS IN
AQUATIC ORGANISMS
Aquatic organisms are able to survive and thrive in heavily pol-
luted environments, showing surprisingly low accumulation of
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FIGURE 2 | Predicted structures of MDR associated members of ABC transporters. (A) Predicted structure of ABCB1 and ABCB11; (B) predicted structure
of “long-chain” ABCC proteins, ABCC1, 2 and 3; (C) predicted structure of ABCG2.
pollutants in body organs (Kurelec and Pivcˇevic´, 1989). Kurelec
and co-workers were the first to demonstrate that aquatic organ-
isms adopt strategies of xenobiotic transport, in order to improve
adaptation to pollutants in their habitats (Kurelec and Pivcˇevic´,
1989, 1991; Kurelec, 1992). To this phenomenon of resistance,
Kurelec coined the term of multixenobiotic resistance (MXR)
(Kurelec, 1992), and identified its biochemical basis as similar
to the one adjacent to the MDR phenotype. The presence of
a drug transporter resembling Pgp (ABCB1) sensitive to vera-
pamil (known inhibitor of human Pgp) was described in two
bivalves species (Anodonta cygnea and Mytilus galloprovinciallis)
(Kurelec and Pivcˇevic´, 1989, 1991). This study was the starting
point for the identification and characterization of the MXR
phenotype in several other species of aquatic organisms, such
as sponges (Kurelec, 1992), molluscs (McFadzen et al., 2000;
Minier et al., 2000; Smital et al., 2003; Luckenbach and Epel,
2008; Faria et al., 2011), crabs and sea urchins (Toomey and
Epel, 1993; Hamdoun et al., 2002). In fish, the presence of ABC
efflux transporters have been described for an increasing number
of species, such as winter flounder (Chan et al., 1992), antarc-
tic fish (Zucchi et al., 2010), rainbow trout (Zaja et al., 2008a;
Fischer et al., 2010; Loncar et al., 2010), zebrafish (Long et al.,
2011a,b; Fischer et al., 2013), mullet (Diaz de Cerio et al., 2012),
killifish (Paetzold et al., 2009), nile tilapia (Costa et al., 2012b,
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2013), catfish (Liu et al., 2013) and seabass (Ferreira et al., 2014)
(Table 2).
Identification of ABC transporters and characterization of
the MXR mechanism has been achieved by the use of several
detection methods, including quantitative or semi-quantitative
reverse transcription polymerase chain reaction (qRT-PCR or
RT-PCR) and in situ hybridization to evaluate mRNA expres-
sion of genes, immunochemical techniques for protein detection
applying mammals monoclonal antibodies to ABCB1 (western
blotting or immunohistochemistry), northern-blotting and activ-
ity assays (through the measurement of efflux or accumulation of
fluorescent model substrates).
Most studies directed to the determination of organ distri-
bution pattern of ABC transporters in aquatic organisms have
been directed to Pgp by the use of the mammalian anti-Pgp
monoclonal antibody (mAb) C219. This mAb which recognizes
an epitope common to all known Pgps (in human MDR1 and
MDR3) and also to Spgp (ABCB11) (Georges et al., 1990; Childs
et al., 1995; van den Elsen et al., 1999). After probing with the
mammalian mAb C219, a protein related to the mammalian
MDR protein was identified in embryos and gills of a few aquatic
invertebrates (Toomey and Epel, 1993; Cornwall et al., 1995).
In fish, positive reaction was seen in the hepatic bile canali-
culi (Kleinow et al., 2000; Doi et al., 2001; Bard et al., 2002a,b;
Klobucˇar et al., 2010; Costa et al., 2013), apical membrane of
enterocytes (Kleinow et al., 2000; Doi et al., 2001; Bard et al.,
2002a; Costa et al., 2013), kidney (Kleinow et al., 2000), and
in endothelial capillaries of brain (Miller et al., 2002). A nega-
tive reaction of the mAb C219 was patent in gills, kidney, gonad,
brain, spleen, heart of killifish and blenny (Bard et al., 2002a,b). In
summary, the suggested Pgp localization in fish reveals a pattern
similar to that described in mammals, with immunoreactive Pgp
occurring in epithelial tissues involved in secretion, absorption or
serving a barrier function, For other ABC efflux transporters no
fish-functional antibodies are available, thus information on their
distribution pattern is quite limited and restricted to the mRNA
expression among the various fish organs.
ABCB1 expression has been detected in different fish species,
and in distinct organs as described in Table 2. These evidences
point to the important role that ABCB1can have also in fish
species validating the research on this Pgp-like proteins. As in
mammals, ABCB11 protein was found to be almost exclusively
expressed in liver, with low expression in proximal intestine, and
very low expression in other organs as gills, brain, gonads and
kidney of trout (Loncar et al., 2010), in trout cell lines (Fischer
et al., 2011) and nile tilapia (Costa et al., 2012b), supporting its
role in the efflux of bile salts from hepatocytes into the bile. For
ABCCs the information available is more limited and efforts in
the last years have increased the information available. In trout,
low ABCC1 expression was found, and kidney was the only organ
showing notable ABCC1 expression while significant expression
levels of ABCC2 in major detoxification organs were reported
(Loncar et al., 2010). In nile tilapia, ABCC1 and ABCC2 were
shown to be expressed in adult organs like liver, gill and intestine
(Costa et al., 2012b) and also in early developmental stages of the
larvae (Costa et al., 2012a). ABCC1 and ABCC2 were also present
in European seabass liver and responsive to a PAH (Ferreira et al.,
2014). HighABCC2 expression was previously reported in kidney,
intestine and liver of little skate (Cai et al., 2003) and in apical
membrane of proximal kidney tubule of killifish (Miller et al.,
2007). Regarding ABCG2, Loncar et al. (2010) have examined the
organ distribution pattern of this protein in trout, and found high
expression levels in gonads andmoderate expression in distal part
of intestine, kidney and brain: previously, expression of ABCG2
was also reported by the same group in trout liver and primary
hepatocytes (Zaja et al., 2008b) (Table 2). Also the studies per-
formed in our group with nile tilapia have shown that ABCG2 is
expressed in barrier organs and at different development stages
(Costa et al., 2012a,b).
Based on these results and on mammal studies, investiga-
tors believe that, in aquatic organisms, ABC efflux transporters
should follow a similar distribution pattern and cellular localiza-
tion, with expression in organs involved in secretion, absorption
or serving as a barrier function, like liver and intestine. Thus,
ABCB1, ABCC2, and ABCG2 should be localized in the api-
cal membrane of polarized cells, pumping substrates into the
intestinal lumen or bile canaliculi, while ABCC1 localization in
basolateral membrane results in the export of its substrates into
the blood. Additionally, ABCB1 should efflux mostly unmodi-
fied compounds, while ABCCs and ABCG2 should efflux organic
anions conjugated by phase II enzymes (Epel et al., 2008).
The bulk of studies conducted in aquatic organisms to eval-
uate the interaction of environmental contaminants with ABC
efflux transporters have been mostly performed on Pgp. Some
compounds, as Pgp model reversal agents (verapamil and/or
cyclosporine A) and xenobiotics (like the insecticide malathion)
were shown to inhibit Pgp activity in fishes, resulting in an
increase of the bioaccumulation of toxic compounds like 2-
aminoanthracene, hydrocarbon-rich Diesel-2 oil, and/or model
Pgp substrates like rhodamine B and rhodamine 123 (Smital
and Kurelec, 1998; Fischer et al., 2013; Ferreira et al., 2014).
Other studies have demonstrated the ability of some xenobi-
otics to induce Pgp expression in fish, such as cadmium (Zucchi
et al., 2010), the organophosphate insecticide chloropyrifos
and the carcinogen N-nitrosodiethylamine (Albertus and Laine,
2001). Similarly, resistance-killifish populations from highly pol-
luted sites also demonstrated enhanced Pgp expression (Cooper
et al., 1999; Bard et al., 2002a) suggesting a protective role
of Pgp. Nevertheless, in another study performed in killifish
from a heavily polluted site with polycyclic aromatic hydro-
carbons (PAHs), polychlorinated biphenyls (PCBs) and heavy
metals, Paetzold et al. (2009) found no up-regulation of hepatic
ABCB1 transcripts. Similarly, after in vivo exposures of fishes to
different xenobiotics, such as prochloraz, nonylphenol diethoxy-
late, ß-naphthoflavone, BaP and 3,4,3′,4′-tetrachlorobiphenyl no
changes were seen in the levels of hepatic and/or intestinal Pgp
(Doi et al., 2001; Sturm et al., 2001; Costa et al., 2012b, 2013). The
study of Pgp in fish species have been given some contradictory
results. A recent study in zebrafish revealed that ABCB4 acted as
the functional multixenobiotic transporter and showed activity as
a barrier to chemical uptake (Fischer et al., 2013). Also in seabass
the difficulty to assess ABCB1 expression (Ferreira et al., 2014)
can be an indication of different transporters to be functional in
different fish species.
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Table 2 | ABC transporters involved the efflux of toxic compounds, fish species where they were identified and tissue distribution pattern in
mammals and fish.
Protein Mammals Fish
Tissue
distribution
Localization in
polarized cell
Specie Common name GenBank
accession number
Tissue
distribution
ABCB1 BBB, liver,
intestine,
kidney,
placenta,
stem cells
Apical Barbus barbus
Carassius auratus
Chelon labrosus
Chondrostoma nasus
Cyprinus carpus
Danio rerio
Dicenthrarchus labrax
Fundulus heteroclitus
Leuciscus cephalus
Mullus barbatus
Oncorhynchus mykiss
Oreochromis niloticus
Plactichthys flesus
Pleuronectes americanus
Poeciliopsis lucida
Scophtalmus maximus
Trematomus bernacchii
Barbel
Goldfish
Gray mullet
Nase
Carp
Zebrafish
European seabass
Killifish
Chub
Red mullet
Rainbow trout
Nile tilapia
European flounder
Winter flounder
Topminnow
Turbot
Rock cod
DQ059069.1
DQ059072.1
HM467814
AY948951.1
AY999964.1
XP_001922717
GQ273979.1
AF099732.1
AY999966
AY850375.1
AY863423.3
GQ911571
AF175686.1
AY053461.1
DQ842514.2
AJ291813
FJ938210.1
Liver, intestine,
kidney, brain,
gonadsa,b,c,d,e,f,g,l,m
ABCB11 Liver Apical Chelon labrosus
Danio rerio
Dicenthrarchus labrax
Fundulus heteroclitus
Oncorhynchus mykiss
Oreochomis niloticus
Platichthys flesus
Gray mullet
Zebrafish
European seabass
Killifish
Rainbow trout
Nile tilapia
European flounder
HM467813
XP_001923538
GQ273980.1
AF135793.1
DQ865266.2
GQ911570
AJ344042.1
liver, intestinea,l,m
ABCC1 Lung, testis,
kidney,
peripheral
blood
mononu-
clear cells,
skeletal and
cardiac
muscle,
placenta
Basolateral
(apical in brain
endothelial
cells)
Barbus barbus
Chelon labrosus
Danio rerio
Dicenthrarchus labrax
Oncorhynchus mykiss
Oreochromis niloticus
Oryzias melastigma
Plactichthys flesus
Poeciliopsis lucida
Trematomus bernacchii
Barbel
Gray mulet
Zebrafish
European seabass
Rainbow trout
Nile tilapia
Medaka
European flounder
Topminnow
Rock cod
FJ890350.1
HM467810
XM_002661202
GQ273982.1
GQ166973.1
GQ911567
JN629038.1
AJ344044.1
HM102361.1
FJ938212.1
testis, ovary,
kidney, muscle,
gills, heart, liver,
intestine, brain,
eyea,h,l,m
ABCC2 BBB, liver,
intestine,
kidney,
placenta,
lung
Apical Carassius auratus
Chelon labrosus
Chondrostoma nasus
Cyprinus carpio
Danio rerio
Dicenthrarchus labrax
Leuciscus cephalus
Mullus barbus
Oncorhynchus mykiss
Oreochromis niloticus
Plactichthys flesus
Poeciliopsis lucida
Trematomus bernacchii
Raja erinácea
Goldfish
Gray mullet
Nase
Carp
Zebrafish
European seabass
Chub
Barbel
Rainbow trout
Nile tilapia
European flounder
Topminnow
Rock cod
Little skate
FJ890349.1
HM467815
AY948950
AY679169
NM_200589.1
GQ273983.1
FJ890348.1
AY275434.1
NM_001124655.1
GQ911569
AJ344045.1
HM102360.1
FJ938211.1
AF486830
liver, kidney,
intestine, brain,
muscle,
gillsa,i,j,k,l,m,n
(Continued)
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Table 2 | Continued
Protein Mammals Fish
Tissue
distribution
Localization in
polarized cell
Specie Common name GenBank
accession number
Tissue
distribution
ABCC3 Adrenal
gland,
Intestine,
Pancreas,
Gallbladder,
Placenta,
Liver,
Kidney,
Prostate
Basolateral Chelon labrosus
Oncorhynchus mykiss
Poeciliopsis lucida
Gray mullet
Rainbow trout
Topminnow
HM467809
GQ888533
DQ842515.1
Liver a,m
ABCC4 Ovary,
Testis,
Kidney,
Lung,
Prostate
Apical,
basolateral
Danio rerio
Oncorhynchus mykiss
Zebrafish
Rainbow trout
NM_001007038.1
BX911853
Livera
ABCC5 Liver, Testis,
Skeletal and
Cardiac
Muscle,
Brain
Basolateral,
apical
Danio rerio
Oncorhynchus mykiss
Zebrafish
Rainbow trout
HQ161064
GU079635
Livera
ABCG2 BBB,
placenta,
liver,
intestine,
breast, stem
cells
Apical Chelon labrosus
Dicenthrarchus labrax
Oncorhynchus mykiss
Oreochromis niloticus
Poeciliopsis lucida
Salmo salar
Gray Mullet
European seabass
Rainbow trout
Nile tilapia
Topminnow
Atlantic salmon
HM467811.1
GQ273981.1
EU163724.1
GQ911568
HM102358.1
NM_011736655.1
liver, kidney,
gonads, intestine,
gillsa,l,m
aLoncar et al., 2010; bKleinow et al., 2000; cDoi et al., 2001; d Bard et al., 2002a; eBard et al., 2002b; f Klobucˇar et al., 2010; gMiller et al., 2002; hLong et al., 2011a;
i Long et al., 2011b; j Miller et al., 2007; k Cai et al., 2003; l Costa et al., 2012b; mDiaz de Cerio et al., 2012; nFerreira et al., 2014.
Few studies have addressed the response of other ABC efflux
transporters upon animals’ exposure to pollutants in compar-
ison to Pgp. Paetzold et al. (2009) described an up-regulation
of hepatic transcripts for ABCC2 and ABCG2 in a multiresis-
tant population of killifish living in a pond heavily polluted with
PAHs, PCBs and heavy metals, while no up-regulation was seen in
ABCB1 and ABCB11 mRNA. Exposure to metals has induced the
expression of ABCC2 in excretory organs of zebrafish including
kidney, liver and intestine (Long et al., 2011b) and also Cd-
exposed Trematomus bernachii (Zucchi et al., 2010). Moreover,
an up-regulation of ABCC2 was seen in red mullet liver from
an oil contaminated site (Della Torre et al., 2010). Long and co-
workers described an up-regulation of ABCC1 gene in ZF4 cells
and embryos of zebrafish exposed to heavy metals (Long et al.,
2011a,b). Increased expression of ABCC2 was observed in seabass
primary hepatocytes (Ferreira et al., 2014) and in Nile tilapia gill
after waterborne exposure to BaP (Costa et al., 2012b). ABCG2
expression was also up-regulated in Nile tilapia intestine upon
BaP exposure (Costa et al., 2012b). These recent studies on MRPs
and BCRP highlight the important role these ABC transporters
may play in the overall detoxification process and cooperation
with phase I and II biotransformation enzymes. Nevertheless
the contribution of the different ABC proteins in the efflux of
xenobiotics has to be conclusively proved.
Although an increased number of compounds have been
shown to interact with ABC efflux transporters, data remains
fragmented and largely restricted to laboratory observations in
comparison to relevant field data. It remains uncertain which
classes of environmental toxicants can induce and/or repress the
activity of these proteins, and to what extent this MXR mech-
anism protects aquatic animals from the toxic action of xeno-
biotics. There is a fundamental need to identify the common
features of ABC efflux transporters substrates, but also the char-
acteristics of chemicals that might inhibit their activity leading to
an increased toxicity of normally effluxed chemicals. Most ABC
efflux transporters are remarkably non-specific with respect to
its substrates. This feature can be an important advantage, as
it provides protection against many classical and novel anthro-
pogenic products, but it can also render the system vulnerable
(Smital et al., 2004; Epel et al., 2008). The presence of multi-
ple substrates that compete for binding sites can saturate these
locations, or directly inhibit the transporter activity, in a phe-
nomenon termed chemosensitization (Bard, 2000; Epel et al.,
2008). MXR inhibitors, or chemosensitizers, were divided in two
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main classes: (1) competitive inhibitors with high affinity that
prevent the binding and active transport of other substrates; and
(2) non-competitive inhibitors that can act in different ways, such
as blocking ATPase activity (Smital et al., 2004). The presence of
MXR inhibitors can compromise the effectiveness of the defense
system, since toxic substances that would normally be excluded,
will remain in the cell and exert their toxic effects (Epel et al.,
2008; Fischer et al., 2013). Ability to inhibit ABC transporters of
aquatic organisms has been described for different types of con-
taminants such as PPCPs, pharmaceuticals, pesticides, fragrances,
among others (Bard, 2000; Smital et al., 2004; Epel et al., 2008;
Fischer et al., 2013), however we still do not know the actual con-
sequences that chemosensitization will have at population and
ecosystem level. Progress in research of these proteins has been
delayedmostly due to the existence of technical limitations, as, for
example, the inexistence of specific probes/antibodies for these
transporters in aquatic organisms, and the measurement of its
functionality. Thus, there is the need to further investigations in
the MXR mechanism in order to fully understand the physiolog-
ical and toxicological functions of ABC transporters in aquatic
organisms, including fish.
FROM PHASE 0 TO PHASE III—A COMPLETE PATHWAY FOR
CELLULAR DETOXIFICATION
Biological membranes are barriers for the uptake, distribution
and elimination of xenobiotics in the organism (Simkiss, 1995).
Bioaccumulation of organic compounds occurs mainly passively,
driven by the compound’s hydrophobicity, and once absorbed,
the xenobiotic may undergo a detoxification pathway, in order
to be excreted from the organism before it exerts toxic effects
(Van Der Oost et al., 2003). The most studied pathway for
cellular detoxification is the biotransformation of xenobiotics
by phase I and phase II enzymes. Biotransformation consists
on a two-phase process of enzymatic reactions that alter the
chemistry of non-polar lipophilic chemicals to polar-water sol-
uble metabolites, leading to the detoxification and elimination
of the parent compound (Black and Coon, 1987; Buhler and
Williams, 1989). The enzymes of phase I metabolism (oxidation,
reduction, hydration, hydrolysis) introduce a functional group
(−OH,−COOH,−NO2, etc.) into the xenobiotic (Commandeur
et al., 1995). Phase II of the biotransformation process involves
the conjugation of the xenobiotic parent compound or its phase
I metabolites with an endogenous ligand, thus facilitating the
excretion of chemicals by the addition of more polar groups
[e.g., glutathione (GSH), glucuronic acid (GA), sulfate] (Schlenk
et al., 2008). In recent years it has been proposed that two
additional steps of drug disposal, called phase 0 and phase III,
are equally important as the biotransformation process (Szakács
et al., 2008). These phases involve the modulation of the cellular
efflux, by ABC transporters, of either unmodified or metabolized
compounds and xenobiotic efflux transporters and biotransfor-
mation enzymesmay be part of a coordinated defense mechanism
that protects cells from xenobiotic insults (Xu et al., 2005).
Thus, understanding the underlying facts behind the possible
cooperative action of efflux transporters and biotransformation
enzymes has critical implications both for human and environ-
mental health. However, despite its relevance, studies focused
on the mechanisms important for this coordinated defense that
protects cells from xenobiotic insults in non-mammalian mod-
els, including fish, are still very scarce (Bard, 2000). Moreover,
the studies published so far did not provide a consistent pat-
tern on the cooperation mechanisms, mostly due to the insuffi-
cient knowledge of the basic parameters of ABC transcriptional
regulation in fish. Intracellular receptors are proteins which,
upon binding of specific ligands, have the ability to regulate
the mRNA transcription of specific genes, thereby controlling
development, homeostasis, and metabolism of the organism (Xu
et al., 2005). From mammalian models, several receptors (e.g.,
Aryl hydrocarbon receptor-AhR, nuclear factor-erythroid 2 p45-
related factor-Nrf2, pregnane X receptor-PXR, peroxisome prolif-
erated activated receptor-PPAR, liver X receptor-LXR, farnesoid X
receptor-FXR, retinoid X receptor-RXR, constitutive androstane
receptor-CAR, glucocorticoid receptor-GR) have been shown to
be key mediators in the regulation of the activity of phase I and
phase II metabolizing enzymes, and ABC transporters involved in
efflux mechanisms (Xu et al., 2005). Some studies in mammalian
in vitromodels have associated some nuclear receptors to the reg-
ulation of expression of ABC transporters (Naspinski et al., 2008;
Chisaki et al., 2009; Rigalli et al., 2011), such as the induction of
expression of phase I and mdr genes via CAR and PXR pathways
(Gu et al., 2013; Wang et al., 2013a,b). Even though in fish there
is a fundamental lack of knowledge on the transcriptional regula-
tion of ABC transporters, in zebrafish an association was shown
between PXR, CYP3A and MDR1 (Bresolin et al., 2005), and
the same pathways of transcriptional regulation of detoxification
enzymes and transporters as in mammals are expected.
However, whether phase I and II enzymes inducers co-
ordinately regulate ABC efflux transporters genes requires
further studies that can shed some light on the role of
receptors, transcription factors and signaling cascades of this
metabolism/transport of endogenous and exogenous compounds
(Xu et al., 2005). Also in mammalian studies, induction of
Pgp has been reported after exposure to known inducers
of phase I (CYP1A) and phase II enzymes, like BaP and
3-methylcholanthrene (3MC) (Chao Yeh et al., 1992; Fardel et al.,
1996). Moreover, ABCC1, ABCC2 and ABCG2 are known to
efflux mainly phase II metabolites, xenobiotics conjugated with
GSH, GA and/or sulfate in mammalian models (for a review see
Leslie et al., 2005), further supporting their role in phase III of the
detoxification process.
Considering the characteristics of common regulation mech-
anisms and complementarity of substrates, it is believed that
ABCB1 acts as a first line of defense preventing unmodified
compounds from accumulating in the cell (phase 0 of cellular
detoxification), while ABCCs and ABCG2 transport phase I and
II metabolites, therefore acting in phase III of cellular detoxifi-
cation (Bard, 2000; Sturm and Segner, 2005; Epel et al., 2008)
(Figure 3). Compared to biotransformation enzymes, research on
efflux transporters is still very limited and has largely been con-
fined to mammalian models. In aquatic organisms, a few studies
have been conducted in an attempt to elucidate this cooperative
mechanism (Cooper et al., 1999; Sturm et al., 2001; Bard et al.,
2002b; Paetzold et al., 2009; Costa et al., 2012b; Ferreira et al.,
2014). The majority of these studies have been confined to the
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FIGURE 3 | Schematic representation of the possible cooperation of
ABC efflux transporters (phase 0 and phase III) and
biotransformation enzymes (phase I and phase II) in cellular
detoxification. In phase 0, ABC transporters (blue circles) efflux the
parent compounds (red stars). Parent compound are biotransformed by
phase I in metabolites (red star with an −OH) that are conjugated on
phase II (red stars with −GSH). Adapted from Bard (2000), with
permission.
study of Pgp and CYP1A, and results suggest that these two pro-
teins should not be coordinately regulated in fish, but enhance
the fact that they may act in complementarity in cellular detox-
ification. More recently, this cooperative role has been pointed
out in nile tilapia exposed to benzo(a)pyrene by showing increase
in expression of both phase I and phase II biotransformation
enzymes as well as the toxicological relevant efflux proteins in bar-
rier organs (Costa et al., 2012b, 2013). However, the database on
the relation between Pgp and biotransformation enzymes in fish
is small and dispersed, and the role of other ABC efflux trans-
porters, besides Pgp, is even more poorly documented. Thus, the
full characterization of this mechanism of cellular detoxification,
where ABC efflux transporters and biotransformation enzymes
display title-roles is yet far from being completely understood.
CONCLUSIONS
Understanding the underlying facts behind the mechanisms of
cellular detoxification has implications both for human and envi-
ronmental health. The medical relevance of these transporters is
evidenced by their MDR abilities and, under this point of view
there is a fundamental need to know how to properly block the
action of these transporters to assure the targeting efficacy of
chemotherapeutic drugs. In addition, the study of ABC efflux
transporters is also very important from an environmental point
of view, since they are believed to be an integral part of the cel-
lular detoxification system. For environmentalists, the goal is to
understand how these efflux transporters keep toxicants out of
the cells, and to ensure that they operate optimally in order to
protect the cells from environmental contaminants. The effects of
ABC transporters on the toxicity of environmental contaminants
is still poorly understood, thus efforts must be made to provide
insights into the interactions of contaminants in fish species. In
particular, interactions with classical and emergent compounds
and the environmental relevance of fish ABC transporters is yet to
be thoroughly addressed. The search for chemosensitizers among
emergent compounds is relevant since some contaminants con-
sidered to be weak or moderately toxic at concentrations found in
the aquatic environment can be potent inhibitors of ABC trans-
porters and modulate toxicity of other xenobiotics and led to
unpredicted effects to exposed species. Therefore, and in particu-
lar with emergent compounds, it is important to evaluate inter-
action of a large array of contaminants with ABC transporters
when assessing toxicity of xenobiotics to the aquatic environment.
One difficulty to fully address the role of ABC transporters in
the detoxification process and the interactions with xenobiotics
with the different classes of contaminants is that the informa-
tion available on fish species is dispersed in different studies with
different goals. So in the future, research must be directed to
the study of regulation of ABC transporters and to unravel the
importance of these efflux proteins to the overall maintenance
of the homeostasis of fish species chronically exposed to foreign
chemicals.
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